NCT05094843

Brief Summary

Lung cancer surgery causes significant changes in the small circulation as well as changes in the intrathoracic anatomy. The effects of lung cancer surgery on electrocardiography and the cardiac stress associated with the procedures have not been previously extensively studied. The aim of the present study is to ascertain whether modern mini-invasive lung cancer surgery causes changes in the electrocardiogram, and whether these changes are transitory during short-term follow-up. Furthermore, the study aims to describe whether lung cancer surgery causes significant cardiac stress detectable by intraoperative electrocardiography.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started Mar 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Mar 2022Dec 2028

First Submitted

Initial submission to the registry

October 1, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

October 26, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

September 10, 2025

Status Verified

September 1, 2025

Enrollment Period

6.8 years

First QC Date

October 1, 2021

Last Update Submit

September 3, 2025

Conditions

Keywords

Lung cancerElectrocardiogramArrhythmia

Outcome Measures

Primary Outcomes (13)

  • Postoperative electrocardiographic p-, R-, and T-wave amplitude changes

    Amplitude changes in the 12-lead rest electrocardiography in millimeters, analyzed daily postoperatively.

    2 weeks

  • Postoperative QRS-duration

    The duration of the QRS-complex in milliseconds in the electrocardiogram, measured daily postoperatively using 12-lead rest electrocardiogram.

    2 weeks

  • Postoperative PQ-delay

    Changes in the PQ-delay in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.

    2 weeks

  • Postoperative QT-interval

    The duration of QT-interval in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.

    2 weeks

  • The postoperative incidence of new bundle branch blocks

    New complete or partial bundle branch blocks, such as RBBB, in the 12-lead rest electrocardiogram.

    2 weeks

  • Postoperative ST-level changes

    ST-level changes in millimeters in the 12-lead rest electrocardiogram

    3 days

  • Postoperative P-wave, QRS-complex, and T-wave axle changes

    The occurrence and type of P-wave, QRS-complex, and T-wave axle changes in the postoperative 12-lead rest electrocardiogram

    2 weeks

  • Postoperative heart rate

    Postoperative heart rate variability in continuous electrocardiographic monitoring

    1 week

  • Postoperative arrhythmias

    Arrhythmia rate as well as their type during the early postoperative period detected by continuous electrocardiogram monitoring

    1 week

  • Perioperative ST-level changes

    The occurrence, duration (in minutes) as well as the magnitude (in millimeters) of perioperative ST-elevation or depression in the continuous perioperative electrocardiographic monitoring.

    1 day

  • Perioperative heart rate variability

    Heart rate levels perioperatively in the continuous perioperative electrocardiographic monitoring.

    1 day

  • Perioperative arrhythmias

    The occurrence and type of perioperative arrhythmias, such as atrial fibrillation or flutter, or ventricular tachycardia in the perioperative electrocardiographic monitoring.

    1 day

  • Perioperative R- and T-wave amplitude changes

    The amplitude (in millimeters) of possible R- and T-wave amplitude changes in the perioperative electrocardiographic monitoring.

    1 day

Secondary Outcomes (2)

  • Postoperative air leak

    1 week

  • Need for reoperation

    1 week

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing elective, curatively aimed, primary lung cancer surgery using mini-invasive surgical techniques.

You may qualify if:

  • Adult patients scheduled for elective lung cancer surgery
  • Willing to participate in the study
  • Curatively aimed surgery
  • Preoperative decision for mini-invasive surgery

You may not qualify if:

  • Participation in any other clinical trial
  • Previous chronic or paroxysmal atrial fibrillation or atrial flutter
  • Cardiac pacemaker
  • History of cardiac conduction disturbances including bundle branch blocks
  • History of cardiac ablation procedures
  • History of previous surgery in the thoracic area including open heart surgery
  • Preoperatively anticipated need for concomitant thoracic wall resection
  • Preoperatively anticipated need for open surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Hospita, Tampere University Hospital

Tampere, Pirkanmaa, 33580, Finland

RECRUITING

MeSH Terms

Conditions

Lung NeoplasmsArrhythmias, CardiacMyocardial Ischemia

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsVascular Diseases

Study Officials

  • Jahangir Khan

    MD, PhD

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2021

First Posted

October 26, 2021

Study Start

March 1, 2022

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

September 10, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations